Apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages and promote the proliferation and migration of ovarian cancer cells by activating the ERK signaling pathway

Zhang,Qun; Li,Hui; Mao,Yiqing; Wang,Xi; Zhang,Xuehui; Yu,Xiuyan; Tian,Junrui; Lei,Zhen; Li,Chang; Han,Qing; Suo,Liping; Gao,Yan; Guo,Hongyan; Irwin,David   M.; Niu,Gang; Tan,Huanran

doi:10.3892/ijmm.2019.4408

Apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages and promote the proliferation and migration of ovarian cancer cells by activating the ERK signaling pathway

Authors:
- Qun Zhang
- Hui Li
- Yiqing Mao
- Xi Wang
- Xuehui Zhang
- Xiuyan Yu
- Junrui Tian
- Zhen Lei
- Chang Li
- Qing Han
- Liping Suo
- Yan Gao
- Hongyan Guo
- David M. Irwin
- Gang Niu
- Huanran Tan
View Affiliations

Affiliations: Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. China, Beijing N&N Genetech Company, Beijing 100082, P.R. China, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, P.R. China, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada
Published online on: November 19, 2019 https://doi.org/10.3892/ijmm.2019.4408
Pages: 10-22
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer has a high rate of recurrence, with M2 macrophages having been found to be involved in its progression and metastasis. To examine the relationship between macrophages and ovarian cancer in the present study, M0 macrophages were stimulated with apoptotic SKOV3 cells and it was found that these macrophages promoted tumor proliferation and migration. Subsequently, the mRNAs and proteins expressed at high levels in these M2 macrophages were examined by RNA‑Seq and quantitative proteomics, respectively, which revealed that M0 macrophages stimulated by apoptotic SKOV3 cells also expressed M2 markers, including CD206, interleukin‑10, C‑C motif chemokine ligand 22, aminopeptidase‑N, disabled homolog 2, matrix metalloproteinase 1 and 5'‑nucleotidase. The abundance of phosphorylated Erk1/2 in these macrophages was increased. The results indicate that apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages by activating the ERK pathway. These results suggest possible treatments for patients with ovarian cancer who undergo chemotherapy; inhibiting M2 macrophage differentiation during chemotherapy may reduce the rate of tumor recurrence.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
2	Kujawa KA and Lisowska KM: Ovarian cancer-from biology to clinic. Postepy Hig Med Dosw (Online). 69:1275–1290. 2015.In Polish. View Article : Google Scholar
3	Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen L, Dong Q and Liu X: LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Biomed Pharmacother. 102:549–554. 2018. View Article : Google Scholar : PubMed/NCBI
4	Liu J and Matulonis UA: New strategies in ovarian cancer: Translating the molecular complexity of ovarian cancer into treatment advances. Clin Cancer Res. 20:5150–5156. 2014. View Article : Google Scholar : PubMed/NCBI
5	Hirata E and Sahai E: Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med. 7:a0267812017. View Article : Google Scholar : PubMed/NCBI
6	Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
7	Aras S and Zaidi MR: TAMeless traitors: Macrophages in cancer progression and metastasis. Br J Cancer. 117:1583–1591. 2017. View Article : Google Scholar : PubMed/NCBI
8	Orihuela R, McPherson CA and Harry GJ: Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 173:649–665. 2016. View Article : Google Scholar :
9	Vinogradov S, Warren G and Wei X: Macrophages associated with tumors as potential targets and therapeutic intermediates. Nanomedicine (Lond). 9:695–707. 2014. View Article : Google Scholar
10	Atri C, Guerfali FZ and Laouini D: Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci. 19:E18012018. View Article : Google Scholar : PubMed/NCBI
11	Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G and De Baetselier P: Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion. Immunobiology. 211:487–501. 2006. View Article : Google Scholar : PubMed/NCBI
12	Bingle L, Brown NJ and Lewis CE: The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol. 196:254–265. 2002. View Article : Google Scholar : PubMed/NCBI
13	Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
14	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
15	Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y and Shimada M: Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction. Cell Commun Signal. 16:542018. View Article : Google Scholar : PubMed/NCBI
16	Wang Z, Gerstein M and Snyder M: RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63. 2009. View Article : Google Scholar
17	Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R and Julkunen I: Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol. 82:710–720. 2007. View Article : Google Scholar : PubMed/NCBI
18	Li X, Wang W and Chen J: Recent progress in mass spectrometry proteomics for biomedical research. Sci China Life Sci. 60:1093–1113. 2017. View Article : Google Scholar : PubMed/NCBI
19	Kaltashov IA, Pawlowski JW, Yang W, Muneeruddin K, Yao H, Bobst CE and Lipatnikov AN: LC/MS at the whole protein level: Studies of biomolecular structure and interactions using native LC/MS and cross-path reactive chromatography (XP-RC) MS. Methods. 144:14–26. 2018. View Article : Google Scholar : PubMed/NCBI
20	Zhong L, Zhou J, Chen X, Lou Y, Liu D, Zou X, Yang B, Yin Y and Pan Y: Quantitative proteomics study of the neuroprotec-tive effects of B12 on hydrogen peroxide-induced apoptosis in SH-SY5Y cells. Sci Rep. 6:226352016. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Zeng C, Wang W, Yu X, Yang L, Chen S and Li Y: Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq. Sci China Life Sci. 58:1282–1287. 2015. View Article : Google Scholar : PubMed/NCBI
23	Genin M, Clement F, Fattaccioli A, Raes M and Michiels C: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 15:5772015. View Article : Google Scholar : PubMed/NCBI
24	Tan Y, Feng Q, Sun X, Xue M, Jiang N and Deng X: Effects of methylseleninic acid on cisplatin-resistant ovarian cancer cells (SKOV3/DDP) and the mechanisms. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 41:1305–1311. 2016.In Chinese; Abstract available in Chinese from the publisher.
25	Zheng P, Luo Q, Wang W, Li J, Wang T, Wang P, Chen L, Zhang P, Chen H, Liu Y, et al: Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E. Cell Death Dis. 9:4342018. View Article : Google Scholar : PubMed/NCBI
26	Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehtiö J, Hertzman Johansson C, et al: Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apop-tosis in melanoma cells. Cell Death Dis. 8:e30292017. View Article : Google Scholar
27	Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, et al: Integrated genomic and epigenomic analysis of breast cancer brain metastasis. PLoS One. 9:e854482014. View Article : Google Scholar : PubMed/NCBI
28	De I, Steffen MD, Clark PA, Patros CJ, Sokn E, Bishop SM, Litscher S, Maklakova VI, Kuo JS, Rodriguez FJ and Collier LS: CSF1 Overexpression promotes high-grade glioma formation without impacting the polarization status of glioma-associated microglia and macrophages. Cancer Res. 76:2552–2560. 2016. View Article : Google Scholar : PubMed/NCBI
29	Piao J, You K, Guo Y, Zhang Y, Li Z and Geng L: Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2. Int J Oncol. 50:2033–2042. 2017. View Article : Google Scholar : PubMed/NCBI
30	Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D, Huang JA and Liu Z: CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer. 16:342017. View Article : Google Scholar : PubMed/NCBI
31	Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F and Ochiya T: Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun. 8:144702017. View Article : Google Scholar : PubMed/NCBI
32	Lin XL, He XL, Zeng JF, Zhang H, Zhao Y, Tan JK and Wang Z: FGF21 increases cholesterol efflux by upregulating ABCA1 through the ERK1/2-PPARγ-LXRα pathway in THP1 macrophage-derived foam cells. DNA Cell Biol. 33:514–521. 2014. View Article : Google Scholar : PubMed/NCBI
33	Goswami KK, Ghosh T, Ghosh S, Sarkar M, Bose A and Baral R: Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cell Immunol. 316:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
34	Niu J and Li Z: The roles of integrin αvβ6 in cancer. Cancer Lett. 403:128–137. 2017. View Article : Google Scholar : PubMed/NCBI
35	Zhang T, Shao B and Liu GA: Rosuvastatin promotes the differentiation of peripheral blood monocytes into M2 macrophages in patients with atherosclerosis by activating PPAR-γ. Eur Rev Med Pharmacol Sci. 21:4464–4471. 2017.PubMed/NCBI
36	Noy R and Pollard JW: Tumor-associated macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014. View Article : Google Scholar : PubMed/NCBI
37	Yu Z, Ye S, Hu G, Lv M, Tu Z, Zhou K and Li Q: The RAF-MEK-ERK pathway: Targeting ERK to overcome obstacles to effective cancer therapy. Future Med Chem. 7:269–289. 2015. View Article : Google Scholar : PubMed/NCBI
38	Kang H, Zhang J, Wang B, Liu M, Zhao J, Yang M and Li Y: Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway. Int J Oncol. 50:545–554. 2017. View Article : Google Scholar : PubMed/NCBI
39	Chanmee T, Ontong P, Konno K and Itano N: Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar